We are international
Donate
TEXT SIZE   


International Myeloma Workshop 2011
PLENARY ABSTRACT SESSION I
Dr. Zhu - Cereblon (CRBN) is a Requirement for the Anti-myeloma Activity of Thalidomide, Lenalidomide and Pomalidomide
Presented by Dr. Keith Stewart
Yuan Xiao Zhu, MD
Mayo Clinic Arizona
Scottsdale, Arizona, USA
May 3-6, 2011
Paris, France
05.06.11


To view the video full screen, click on the small button next to the volume control in the lower right hand corner.


 related articles